Objective: To examine the consequences of single iron depletion on health in menstruating women, a common but rarely investigated situation in industrialized countries. Design: We studied data issued from the SU.VI.MAX. cohort via a transversal and a longitudinal (2-y follow-up) approach. Subjects and methods: Iron-depleted menstruating women (ferritin o15 mg/l, n ¼ 472) were compared with iron-sufficient (ferritin 30-80 mg/l, n ¼ 393) menstruating women (aged 35-51 y) in terms of health variables and quality of life (DUKE score) using logistic regression and analysis of variance. Results: The risk of any infection or of specific types of infections was not increased by iron deficiency. Regarding the DUKE health profile, no specific score was significantly different between the two groups: only the scores reflecting 'physical health' (P ¼ 0.09) and 'perceived health' (P ¼ 0.12) showed a trend toward a lower level, while the best score for 'mental health' (P ¼ 0.11) was found in the group of iron-depleted women. The only significant difference between iron-depleted and ironsufficient women concerned memory disorders, which were significantly less common in iron-depleted women, Odds ratio ¼ 0.7 (0.6-0.9; P ¼ 0.03). Conclusion: There is no conclusive evidence that an absence of iron stores has negative consequences; however, we must consider that in the case of a worsening of the iron balance, it may lead to a rapid decrease in the level of functional compounds. Sponsorship: The laboratory Robapharm, Pierre Fabre, France.
Introduction
Iron deficiency is the most common known form of nutritional deficiency disorders in the world (CDC, 1998 ; UNICEF/WHO/UNU/MI, 1998). Although it is mainly a problem in developing countries, it is also well known to affect large fractions of the population in the industrialized world (Fogelholm et al, 1993; CDC, 1998; Galan et al, 1998) .
While the prevalence of iron deficiency anemia is still relatively high among some groups of the population, such as pregnant women and young children, iron depletion, that is, low iron stores without anemia, is a commonly observed situation, especially in menstruating women. Nutritional studies performed in industrialized countries, using serum ferritin as a marker of iron stores, underline the fact that the prevalence of iron depletion in women of childbearing age varies between 16 and 30% (Fogelholm et al, 1993; Hallberg et al, 1995; Hallberg & Asp, 1996; CDC, 1998; Galan et al, 1998) .
Such a situation, in the context of the abundance of food in developed countries, may be related to the rapid evolution of the diet and modifications in the way of life over the last few decades (Hallberg & Asp, 1996; Galan et al, 1998; Hallberg et al, 1998) . Indeed, in the last few generations, we have observed, in industrialized countries, a reduction in total calorie intake (because of a reduction in physical activity), which has led to a decrease in iron intake along with that of most other dietary micronutrients. Moreover, the increase in consumption of foods containing only energy, without trace elements or vitamins, has contributed to a decrease in the micronutrient density per unit of energy in the diet, especially regarding iron. For these reasons, the usual diets in developed countries may no longer meet the iron requirements of a number of people, particularly those with high iron requirements, including menstruating women, considered at high risk of iron deficiency. Some factors, such as type of contraception in women, blood donation or minor pathological blood loss (hemorrhoids, gynecological bleeding), considerably increase the difficulty of covering iron needs. Moreover, women, especially those consuming low-energy diets, vegetarians and vegans are at particularly high risk of iron deficiency (Hercberg et al, 1990; Hallberg et al, 2000) .
At the stage of anemia, the ultimate stage of iron deficiency, deleterious consequences on health are well known, and iron supplementation should be provided. However, in the absence of anemia, there is no clear evidence of deleterious consequences of iron depletion, even though in the human body, iron is present in all cells and has several vital functions. Iron not only intervenes as a carrier of oxygen from the lungs to the tissues in the form of hemoglobin, but also as a facilitator of oxygen use and storage in the muscles as myoglobin, as a transport medium for electrons within the cells in the form of cytochromes and as an integral part of enzyme reactions in various tissues. The hypothesis may be raised that iron depletion in itself could result in a decrease in intellectual performance and physical capacity during exercise, and could produce alterations in temperature regulation, immune functions, gestation, and other fundamental metabolic activities (Hallberg & Asp, 1996 ; UNICEF/WHO/UNU/MI, 1998). Several controlled studies with placebo have shown that iron supplementation in teenagers improves symptoms even in nonanemic subjects (Hercberg et al, 2001) .
In order to further understand the consequences on health of single iron depletion, we undertook a study to compare health variables known to be potentially related to the iron status, in groups of women with chronically depleted or sufficient iron stores. This study was carried out on menstruating adult women participating in the SU.VI.MAX. cohort study.
Subjects and methods

Subjects
The study population was part of the SU.VI.MAX. cohort. The SU.VI.MAX. study is a randomized double-blind, placebo-controlled, primary prevention trial designed to test the efficacy of daily supplementation with antioxidant vitamins (A, C and b-carotene) and minerals (selenium and zinc) at nutritional doses, in reducing the major health problems in industrialized countries, and especially the main causes of premature death; 12 735 eligible subjects (twothirds of whom were women aged 35-60 y, while one-third were men aged 45-60 y) were included in a basal evaluation in 1994 and are being followed up for 8 y (Hercberg et al, , 1999 . Participants underwent a yearly visit consisting, every alternate year, of biological sampling or a clinical examination. Data on baseline characteristics of the participants suggest that the present sample is, for the selected age groups, close to the national population in terms of geographic density and socioeconomic status. The SU.VI. MAX. study has been approved by the ethical committee for studies with human subjects (CCPPRB no. 706) of ParisCochin, and the 'Commission Nationale Informatique et Liberté' (CNIL no. 334641), which advocates that all medical information be confidential and anonymous.
Biochemical measurements
In 1994 (inclusion) and in 1996, 35 ml of venous blood was obtained after a 12-h fasting period in order to assess several biological parameters. To measure serum ferritin, blood was centrifuged and a nephelometric assay (BNII Behring) was used. The laboratory quality assurance included analysis of serum from standard pools with each run and international standards. The same standards were used for the initial and the 2-y ferritin assays (Hallberg & Asp, 1996) .
Collected health variables
Three different types of questionnaires were used for collecting data on health status:
(1) The questionnaire at inclusion, in which we retained several items potentially related to the iron deficiency status (Hallberg & Asp, 1996 ; UNICEF/WHO/UNU/MI, 1998): palpitations, general feeling about health status, inability to concentrate, sleeping disorders, memory disorders, vertigo and fainting, nervousness, koilonychia, cheilitis, heartburn and glossitis.
(2) The DUKE health profile (Parkerson et al, 1991; Guillemin et al, 1997; Bouchet et al, 2000 Bouchet et al, ) (filled in 1995 that contained information about quality of life divided into 10 categories: physical, mental, social, general, perceived, self-esteem, anxiety, depression, pain and disability. For each category, scores range from 0 (worse situation) to 100 (optimal situation).
(3) The monthly health questionnaires in which all health events that had occurred during the past month (diseases, surgery, treatments, medical and paramedical consultations, hospitalizations and number of days of sick leave) were spontaneously recorded by the subjects and transmitted by telephone using the French Telematic Network, Minitel and an electronic device specifically developed for the SU.VI. MAX. study . We retained the following variables: infections (as total numbers of infections, respiratory infections, urogenital infections, and other infections, ie nonrespiratory and nonurogenital infections), total numbers of medical consultations, paramedical consultations, Definitions of iron status and constitution of groups 'Iron depletion' was defined as a serum ferritin level below 15 mg/l, and 'normal iron status' as a serum ferritin level between 30 and 80 mg/l. 'Chronic iron depletion' corresponded to a serum ferritin level below 15 mg/l both at inclusion and at 2 y, and 'chronic iron sufficiency' corresponded to a serum ferritin level above 30 mg/l (and below 80 mg/l) both at inclusion and at 2 y. Serum ferritin concentration was measured at inclusion in all SU.VI.MAX. subjects . A specific protocol was elaborated for monitoring the 2-y iron status in a subgroup of women. We calculated that 400 irondepleted and 400 iron-sufficient women were needed to give the study a power of 80%, at an alpha level of 5%, to detect a significant OR of 1.6 for the main criterion 'total infections'. Considering that the two groups represented approximately 50% of all women, we randomly selected 1600 women from the total cohort in order to measure the 2 y iron status. This protocol did not include additional constraints for the subjects, as the sample was part of the routine blood sampling of the whole cohort. From the 1600 randomly selected women, only 1505 could be studied because of insufficient samples (n ¼ 40), errors in numbering the samples (n ¼ 22) or women who did not attend the sampling session (n ¼ 33). We then excluded women who were known to be postmenopausal (n ¼ 51) and those over 51 y of age for whom the menopausal status was unknown (n ¼ 86), since natural menopause rarely occurs before this age (Collaborative Group on Hormonal Factors in Breast Cancer, 1997). We finally excluded women with either a baseline or a 2 y ferritin concentration above 80 mg/l (n ¼ 43) in order to minimize the risk of including iron-depleted subjects who had high ferritin concentrations as a consequence of infectious or inflammatory conditions (Hallberg, 1995; Hulthen et al, 1998) .
The chronically iron-depleted group comprised 472 women (among these, 41 had anemia defined as a hemoglobin concentration below 120 g/l Zhu & Haas, 1997) ) and the 'iron-sufficient group' included 393 women.
In addition to studying chronic iron depletion, we investigated a dose-effect relation using only the 2-y serum ferritin concentration in four categories: ferritin concentration 30-80 mg/l, the reference category, n ¼ 471; 30-15 mg/l, n ¼ 319; 10-15 mg/l, n ¼ 132; and 10 mg/l and below, n ¼ 403.
Statistical analysis
We performed both a transversal analysis, which evaluated the relation between depleted iron stores and health variables estimated at baseline or at a 1-y follow-up (DUKE scores), and a longitudinal analysis, aimed at evaluating the impact of the level of iron stores on subsequent medical events (2-y follow-up).
Because of their semiquantitative distribution, dependent variables were transformed into qualitative variables. The health variables were transformed into four levels. The reference category corresponded to subjects who had never had the studied event. Subjects who had ever had the event were divided into the following three categories based on a tertile distribution: rarely, sometimes and often. When there was no major difference between two adjacent categories, categories were grouped together and the variable was then studied as a dichotomous variable.
Data were analyzed, for the health variables, with logistic regression (simple or polynomial), considering the serum ferritin level as the independent variable. The model was built up as logit P ¼ a+b Â serum ferritin concentration (P is the probability of sickness when the serum ferritin level is below 15 mg/l). The statistical significance of the ORs was calculated by the likelihood ratio test. DUKE scores were analyzed with analysis of variance.
In multivariate analysis, the potentially confounding effects of age, use of an intrauterine device and use of oral contraception were tested by including these variables in the model as independent variables, in addition to the serum ferritin level (Zhu and Haas, 1997; Galan et al, 1998) . Data were compiled on an Alpha-VMS system using SAS and a specific database developed for handling the data by SAS.
Results
Mean serum ferritin (7s.d.) was 8.2 mg/l (74.0) in the chronic iron-depleted group and 46.1 mg/l (712.8) in the iron-sufficient group. ORs (with their 95% confidence intervals) for the health variables collected in the baseline questionnaire according to the iron status are presented in Table 1 , taking the iron-sufficient group as the reference category. Chronic iron-depleted stores were associated with a significant reduction in memory disorders, with an OR of 0.7 (0.6-0.9; P ¼ 0.03) for iron-depleted women. There was a tendency for a reduction in cheilitis, glossitis, palpitations and inability to concentrate, but confidence intervals all included 1. However, there was also a trend toward an increase in nervousness, as well as vertigo and fainting, and koilonychia, but ORs were not significantly different from 1.
In total, 85% of women returned the DUKE questionnaire. An additional 1-2.5% of DUKE scores could not be calculated because of no response to at least one of the 17 DUKE items. Since the general DUKE score was the sum of three DUKE scores (physical, mental and social), it had the highest proportion of missing values. Results of the analysis of variance of the DUKE scores are presented in Table 2 . No score was significantly different between the two groups.
Iron depletion in menstruating women N Duport et al Lower scores for physical health (P ¼ 0.09) and perceived health (P ¼ 0.12), and higher scores for mental health (P ¼ 0.11) were observed in iron-depleted women.
Longitudinal 2-y data are presented in Table 3 for health variables according to the initial serum ferritin level (irondepleted vs iron-sufficient). There was no significant difference at the 5% level. Iron-depleted women tended to have 8 or more days of fever more frequently than iron-sufficient women, OR ¼ 1.5 (0.9-2.6; P ¼ 0.12). There was a slight, but nonsignificant, trend toward an increase in antibiotic- For each item, the score ranges from 0 (worse situation) to 100 (optimal situation). Iron depletion in menstruating women N Duport et al treated infections of the genitourinary tract and of the respiratory tract. In contrast, there was a decrease in antibiotic-treated skin and dental infections (named 'other infections'), in paramedical consultations (0-5 vs 6 and more), and in days of sick leave (0-7 days vs 8 or more). In multivariate analysis, when including potential confounders such as age, intrauterine devices and oral contraception in the model, results were unmodified. In order to investigate a potential dose-effect relation between serum ferritin level and the studied variables, in particular in order to investigate whether 'severe' iron depletion, that is, serum ferritin concentration below 10 mg/l, conveyed a more significant relation with any variable, polynomial logistic regression was performed considering the 2-y serum ferritin level in four groups, 0-10, 10-15, 15-30 and 30-80. Memory disorders remained significantly and inversely associated with serum ferritin, with a stronger effect for levels below 10 mg/l, that is, ORs were 1.0 for a serum ferritin level between 30 and 80 mg/l, 1.1 (0.4-2.8; P ¼ 0.8) for a 15-30 mg/l ferritin concentration, 0.9 (0.6-1.2; P ¼ 0.45) for a 10-15 mg/l ferritin concentration and 0.6 (0.4-0.8; P ¼ 0.003) for a serum ferritin below 10 mg/l. No other studied variable displayed a significant dose-effect relation; in particular, no effect was observed for severe iron depletion on any type of infection.
Discussion
To our knowledge, our study is the only one that has investigated the consequences of iron depletion on health parameters not only on retrospective or transversal data, but also in a prospective way. Indeed, most studies on iron deficiency considered only the consequences on health of iron deficiency anemia (Hallberg & Asp, 1996; Walter et al, 1997 ; UNICEF/WHO/UNU/MI, 1998). We have investigated the health variables most commonly associated with iron deficiency anemia in the literature (Hallberg & Asp, 1996 ; UNICEF/WHO/UNU/MI, 1998). Among these, surprisingly, memory disorders appeared as significantly less frequent in women with serum ferritin concentrations below 15 mg/l, or even more so, below 10 mg/l. Others demonstrated that, in rodents, iron deficiency without anemia protected against the neurodegeneration of specific cerebral zones, in particular, the hippocampus zone (Hallberg & Asp, 1996) , one of the memory zones (Bohbot et al, 2000) , whereas subjects with iron-deficient anemia presented more frequently with memory loss because of major alterations of enzymatic reactions of the serotonin metabolism (mitochondrial aldehyde oxidase) or of catecholamines catabolism (mitochondrial monoamine oxidase) within the neuronal mitochondria, leading to a cerebral storage of triptaminergic derivatives and of catecholamines (adrenaline, noradrenaline and dopamine) (Youdim et al, 1983 (Youdim et al, , 1989 Hallberg & Asp, 1996; Youdim & Yehuda, 2000; Erikson et al, 2001 ).
We also investigated the consequences of iron deficiency in terms of quality of life using the DUKE health profile. There was no significant impact of iron deficiency on any component of the Duke score, although there was a trend toward a decrease in physical health and perceived health scores as well as an improvement in the mental health score (P ¼ 0.11) in iron-deficient women. The latter may be related to the observed beneficial effect on memory disorders, as well as on the inability to concentrate (although the latter was not significant). The former may be because of the impact of iron depletion on some alterations of the muscular enzymatic reactions, especially reactions of oxidative phosphorylation responsible for energy synthesis (Hallberg & Asp, 1996; Haas & Brownlie, 2001 ).
In our study, probably because we included mainly women with nonanemic iron depletion, we failed to observe several abnormalities that have been frequently associated with iron-deficient anemia, especially infections. Our study of infections was very detailed and enabled us to investigate whether any specific type of infection, of the respiratory tract, the genitourinary tract or others, such as skin or dental infections, was possibly associated with iron depletion. We studied both, any infection as assessed by the subjects themselves and infections documented by the prescription of antibiotics. No type of infection was increased in irondepleted women, and we even observed that nonrespiratory and nongenitourinary infections, that is, mainly dental (37.5%) and skin (44.4%) infections, were reduced in irondepleted women compared with iron-sufficient women. In the literature, the relation between infections and the iron status is very controversial. Some in vitro studies demonstrated that iron deficiency inhibited bacterial proliferation, whereas others indicate that this effect is balanced by numerous alterations of the immune system induced by iron deficiency, such as a decrease in delayed hypersensitivity through abnormalities in lymphocyte transformation, and functional abnormalities of the polymorphonuclear leukocytes (Dallman, 1987; Hallberg & Asp, 1996; Walter et al, 1997; Al-Younes et al, 2001 ). However, the latter studies investigated iron deficiency with anemia. It is possible that in our study, in which iron-depleted women were mostly nonanemic, the iron deficiency was not severe enough to induce severe immune abnormalities, which could counterbalance the bacteriostatic effect of iron deficiency. Another possible explanation comes from a classical limitation of cohort studies, that is, the healthy volunteer effect. Therefore, we cannot entirely rule out, for example, an effect of iron depletion on severe or frequent infections because such events were rare in our cohort, which was possibly because of the group being more healthy than the general population.
Disorders of the skin, mucous membranes, nails and hair (glossitis, cheilitis, koilonychia and gastric burns) also were not associated with iron depletion in our study. Again, the iron store may have been sufficient so as not to impair the cutaneomucous turnover, in particular, through dysfunction of collagen synthesis via alterations of lysine oxidase, or to affect cell replacement through alterations in nucleotidase reductase (Prasad & Prasad, 1991; Sato, 1991) .
The strengths and limitations of our study must be discussed. One of the limitations is the fact that this is an intervention study; half of the women received a daily supplementation of zinc, selenium, vitamins C and E, and bcarotene, at nutritional doses. When considering only women with a stable iron status, the intervention could theoretically unbalance the iron status groups with regard to their supplementation. The 120 g of daily supplementation with vitamin C could possibly increase the intestinal absorption of nonheme dietary iron. However, because of the low level of supplementation, this could only play a role in low heme-iron consumers. Indeed, a diversified diet supplies iron in two different forms, nonheme iron of vegetal origin, which has a low bioavailability, and heme iron of animal origin, which has a high bio availability, unmodified by vitamin C intake (CDC, 1998; Galan et al, 1998; Hallberg et al, 1998) . As our study did not include any vegan or vegetarian subjects, the randomized supplementation should not induce any significant bias. In addition, when studying the entire group of women, and not only those chronically depleted, the results were unmodified. Another pitfall of our study design is the potential beneficial effect of supplementation on the studied outcomes. This could result in a lower overall number of events, thus reducing the power of our study to detect small differences. However, as ORs were close to 1.0 especially for infectious events, the clinical relevance of such small differences between groups, even if found statistically significant, is questionable.
We excluded all subjects with a very high ferritin value, above 80 mg. Indeed, inflammatory or infectious events may induce high ferritin concentrations, and subjects with such high values may represent a particularly unhealthy population (Hallberg, 1995; Hulthen et al, 1998) . Another limitation of our study is the low number of anemic women, 41, which is in accordance with the literature (Fogelholm et al, 1993; CDC, 1998; Galan et al, 1998) but did not enable separate analyses of the same health variables. Exclusion of these 41 women from the analyses did not change our results (all having a concentration of ferritin o15 mg/l). Therefore, we can only conclude that iron depletion without anemia has little impact on the measured health variables; however, we can make no further conclusions regarding severe iron deficiency associated with anemia.
Iron status may vary over time. Since we sought to study contrasted and constant-over time iron status, we included, in the iron-depleted group, only subjects with a ferritin concentration below 15 both at inclusion and at 2-y examination; the same was true for the iron-sufficient group. This lends more strength to our findings, indicating that chronic iron depletion has little impact on health variables. However, since we could not rule out an effect of temporary iron deficiency, we also tested the impact of the 2-y iron status alone on all tested variables. There was no significant difference from the main analyses and, in particular, no additional variable appeared to be significantly associated with iron depletion.
In conclusion, in view of these results, there is no conclusive evidence that an absence of iron stores has negative consequences. However, it is essential to take into consideration the fact that worsening of the iron balance may lead to a rapid decrease in the level of functional compounds. Taking into account the deleterious effects of iron deficiency on health (particularly iron deficiency anemia) and its high prevalence, prevention of this disorder is particularly relevant and may be implemented by different, but complementary, means: information about appropriate dietary habits, iron supplementation of specific groups at high risk such as pregnant women, and iron fortification of foods specifically oriented toward certain physiological groups, such as children.
